| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.796 | 0.003 | 0.796 | Alpha adrenoreceptor agonist | 0.148 0.017 CID_154699714 | ||
| 0.627 | 0.002 | 0.627 | Alpha 2 adrenoreceptor agonist | 0.151 0.006 CID_154699714 | ||
| 0.552 | 0.001 | 0.552 | Alpha 2a adrenoreceptor agonist | 0.201 0.002 CID_154699714 0.017 0.013 CID_154699676 | ||
| 0.431 | 0.003 | 0.431 | Prostacyclin antagonist | 0.246 0.003 CID_154699714 0.138 0.004 CID_154699676 | ||
| 0.427 | 0.004 | 0.427 | Alpha 1 adrenoreceptor agonist | 0.053 0.046 CID_154699714 | ||
| 0.419 | 0.007 | 0.419 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.267 0.033 CID_154699714 0.135 0.089 CID_154699676 | ||
| 0.374 | 0.009 | 0.374 | Antiadrenergic | 0.162 0.033 CID_154699714 | ||
| 0.371 | 0.009 | 0.371 | Adrenaline antagonist | 0.16 0.032 CID_154699714 | ||
| 0.316 | 0.004 | 0.316 | Adrenaline agonist | 0.133 0.02 CID_154699714 | ||
| 0.317 | 0.023 | 0.317 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.149 0.121 CID_154699714 0.148 0.122 CID_154699676 | ||
| 0.295 | 0.005 | 0.295 | ALK inhibitor | 0.131 0.025 CID_154699714 | ||
| 0.24 | 0.002 | 0.24 | Alpha 1a adrenoreceptor agonist | 0.197 0.002 CID_154699714 0.084 0.004 CID_154699676 | ||
| 0.254 | 0.026 | 0.254 | Protein kinase (CK1) gamma 3 inhibitor | 0.159 0.079 CID_154699714 | ||
| 0.223 | 0.026 | 0.223 | Protein kinase (CK1) gamma 2 inhibitor | 0.099 0.085 CID_154699714 | ||
| 0.326 | 0.141 | 0.731 | Cyclophilin D inhibitor | 0.435 0.073 CID_154699714 0.731 0.011 CID_154699676 | CID_154699676 | |
| 0.182 | 0.002 | 0.182 | Alpha 2c adrenoreceptor agonist | 0.039 0.004 CID_154699714 | ||
| 0.18 | 0.005 | 0.18 | Thioredoxin reductase inhibitor | 0.126 0.015 CID_154699714 0.12 0.017 CID_154699676 | ||
| 0.23 | 0.06 | 0.23 | Death-associated protein kinase 3 inhibitor | |||
| 0.209 | 0.041 | 0.209 | Protein kinase (CK1) gamma inhibitor | |||
| 0.204 | 0.043 | 0.204 | Polo-like kinase-3 inhibitor | |||
| 0.196 | 0.037 | 0.196 | Bone formation stimulant | 0.116 0.09 CID_154699714 0.157 0.054 CID_154699676 | ||
| 0.167 | 0.013 | 0.179 | Thioredoxin inhibitor | 0.122 0.029 CID_154699714 0.179 0.011 CID_154699676 | CID_154699676 | |
| 0.155 | 0.004 | 0.155 | Vitronectin receptor antagonist | 0.041 0.008 CID_154699714 0.022 0.014 CID_154699676 | ||
| 0.182 | 0.037 | 0.182 | Cholinergic antagonist | |||
| 0.231 | 0.1 | 0.336 | Spasmolytic | 0.336 0.057 CID_154699676 | CID_154699676 | |
| 0.133 | 0.004 | 0.133 | Alpha 1b adrenoreceptor agonist | 0.094 0.005 CID_154699714 0.062 0.018 CID_154699676 | ||
| 0.126 | 0.002 | 0.126 | Alpha 1L adrenoreceptor agonist | 0.105 0.003 CID_154699714 0.074 0.005 CID_154699676 | ||
| 0.137 | 0.022 | 0.137 | Telomerase inhibitor | |||
| 0.146 | 0.034 | 0.146 | Alpha 2c adrenoreceptor antagonist | |||
| 0.115 | 0.005 | 0.115 | Acetylcholine M2 receptor agonist | 0.081 0.013 CID_154699714 0.064 0.025 CID_154699676 | ||
| 0.198 | 0.089 | 0.198 | EphB2 antagonist | |||
| 0.181 | 0.075 | 0.181 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.226 | 0.136 | 0.257 | Caspase 3 stimulant | 0.257 0.107 CID_154699676 | CID_154699676 | |
| 0.102 | 0.015 | 0.343 | NMDA 2B receptor antagonist | 0.343 0.004 CID_154699714 | CID_154699714 | |
| 0.084 | 0.003 | 0.084 | Alpha 2d adrenoreceptor agonist | 0.053 0.004 CID_154699714 0.027 0.01 CID_154699676 | ||
| 0.163 | 0.083 | 0.184 | Phospholipase C inhibitor | 0.184 0.056 CID_154699714 0.138 0.132 CID_154699676 | CID_154699714 | |
| 0.085 | 0.004 | 0.085 | Integrin alphaVbeta3 antagonist | 0.025 0.012 CID_154699714 | ||
| 0.182 | 0.104 | 0.182 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.172 | 0.103 | 0.172 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.065 | 0.002 | 0.065 | Integrin beta6 antagonist | 0.032 0.003 CID_154699714 0.025 0.003 CID_154699676 | ||
| 0.109 | 0.047 | 0.109 | DNA directed RNA polymerase inhibitor | 0.101 0.055 CID_154699714 | ||
| 0.174 | 0.115 | 0.174 | Dyrk kinase inhibitor | |||
| 0.141 | 0.085 | 0.141 | Cholinergic | |||
| 0.134 | 0.079 | 0.134 | Protein kinase C nu inhibitor | |||
| 0.098 | 0.049 | 0.098 | Alpha 2 adrenoreceptor antagonist | |||
| 0.049 | 0.004 | 0.049 | Integrin alphaVbeta1 antagonist | 0.02 0.012 CID_154699714 | ||
| 0.106 | 0.07 | 0.106 | Alpha 2b adrenoreceptor antagonist | |||
| 0.041 | 0.008 | 0.041 | CXC chemokine 2 receptor antagonist | |||
| 0.181 | 0.152 | 0.308 | DNA synthesis inhibitor | 0.308 0.041 CID_154699676 | CID_154699676 | |
| 0.056 | 0.028 | 0.056 | CXC chemokine 1 receptor antagonist | |||
| 0.127 | 0.1 | 0.127 | Acetylcholine M1 receptor antagonist | |||
| 0.083 | 0.058 | 0.083 | Acetylcholine M3 receptor agonist | |||
| 0.03 | 0.007 | 0.03 | Imidazoline I1 receptor antagonist | |||
| 0.03 | 0.008 | 0.03 | Integrin beta5 antagonist | |||
| 0.027 | 0.005 | 0.027 | Alpha 2b adrenoreceptor agonist | |||
| 0.031 | 0.01 | 0.031 | Complement factor 1r inhibitor | 0.027 0.015 CID_154699714 | ||
| 0.111 | 0.091 | 0.111 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.099 | 0.079 | 0.099 | 5 Hydroxytryptamine antagonist | |||
| 0.121 | 0.104 | 0.121 | Aurora-C kinase inhibitor | |||
| 0.068 | 0.054 | 0.103 | NMDA 2 receptor antagonist | 0.103 0.031 CID_154699714 | CID_154699714 | |
| 0.059 | 0.046 | 0.059 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.138 | 0.126 | 0.138 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.069 | 0.059 | 0.069 | Alpha 2a adrenoreceptor antagonist | |||
| 0.145 | 0.14 | 0.145 | Focal adhesion kinase 2 inhibitor | |||
| 0.16 | 0.174 | 0.219 | RNA-directed DNA polymerase inhibitor | 0.219 0.075 CID_154699714 | CID_154699714 | |
| 0.164 | 0.218 | 0.39 | Angiogenesis inhibitor | 0.39 0.057 CID_154699714 0.275 0.106 CID_154699676 | CID_154699714 | |
| 0.072 | 0.128 | 0.11 | DNA polymerase I inhibitor | 0.11 0.076 CID_154699676 | CID_154699676 | |
| 0.057 | 0.157 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.05 CID_154699676 | CID_154699676 | |
| 0.005 | 0.13 | 0.019 | Sodium/hydrogen exchanger inhibitor | 0.019 0.01 CID_154699714 | CID_154699714 | |
| 0.049 | 0.185 | 0.109 | UDP-glucose 4-epimerase inhibitor | 0.109 0.051 CID_154699676 | CID_154699676 | |
| 0.103 | 0.252 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.049 CID_154699676 | CID_154699676 | |
| 0.037 | 0.188 | 0.135 | Topoisomerase I inhibitor | 0.135 0.047 CID_154699676 | CID_154699676 | |
| 0.072 | 0.226 | 0.26 | Dual specificity phosphatase 3 inhibitor | 0.26 0.037 CID_154699714 | CID_154699714 | |
| 0.045 | 0.243 | 0.124 | AMP-activated protein kinase stimulant | 0.124 0.045 CID_154699676 | CID_154699676 | |
| 0.104 | 0.323 | 0.266 | Alpha-glucosidase inhibitor | 0.266 0.178 CID_154699676 | CID_154699676 | |
| 0.06 | 0.286 | 0.216 | Dual specificity phosphatase inhibitor | 0.216 0.047 CID_154699714 | CID_154699714 | |
| 0.05 | 0.286 | 0.172 | Cyclooxygenase 3 inhibitor | 0.172 0.032 CID_154699676 | CID_154699676 | |
| 0.031 | 0.267 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.036 CID_154699714 | CID_154699714 | |
| 0.021 | 0.395 | 0.112 | Topoisomerase II inhibitor | 0.112 0.074 CID_154699676 | CID_154699676 | |
| 0.007 | 0.391 | 0.044 | NMDA 2D receptor antagonist | 0.044 0.009 CID_154699714 | CID_154699714 | |
| 0.032 | 0.436 | 0.149 | Cell wall synthesis inhibitor | 0.149 0.066 CID_154699676 | CID_154699676 | |
| 0.067 | 0.489 | 0.476 | Antibacterial | 0.476 0.048 CID_154699676 | CID_154699676 | |
| 0.016 | 0.498 | 0.05 | Factor IXa inhibitor | 0.05 0.038 CID_154699714 | CID_154699714 | |
| 0.005 | 0.503 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.024 0.017 CID_154699676 | CID_154699676 | |
| 0.003 | 0.524 | 0.132 | Cholecystokinin B antagonist | 0.132 0.005 CID_154699714 | CID_154699714 | |
| 0.04 | 0.568 | 0.338 | Antithrombotic | 0.338 0.069 CID_154699676 | CID_154699676 | |
| 0.004 | 0.536 | 0.082 | Antineoplastic antibiotic | 0.082 0.056 CID_154699676 | CID_154699676 | |
| 0.017 | 0.577 | 0.209 | Immunostimulant | 0.209 0.115 CID_154699676 | CID_154699676 | |
| 0.073 | 0.642 | 0.328 | Interleukin 2 agonist | 0.328 0.056 CID_154699676 | CID_154699676 | |
| 0.015 | 0.599 | 0.189 | Thrombolytic | 0.189 0.057 CID_154699676 | CID_154699676 | |
| 0.003 | 0.621 | 0.139 | Cholecystokinin antagonist | 0.139 0.005 CID_154699714 | CID_154699714 | |
| 0.009 | 0.63 | 0.069 | Thrombin inhibitor | 0.069 0.056 CID_154699714 | CID_154699714 | |
| 0.021 | 0.644 | 0.115 | Toll-Like receptor 4 antagonist | 0.115 0.049 CID_154699676 | CID_154699676 | |
| 0.003 | 0.628 | 0.196 | Cholecystokinin A antagonist | 0.196 0.005 CID_154699714 | CID_154699714 | |
| 0.071 | 0.698 | 0.323 | Peptidyltransferase inhibitor | 0.323 0.018 CID_154699676 | CID_154699676 | |
| 0.027 | 0.675 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.048 CID_154699676 | CID_154699676 | |
| 0.01 | 0.66 | 0.058 | Antibiotic Aminoglycoside-like | 0.058 0.009 CID_154699676 | CID_154699676 | |
| 0.016 | 0.67 | 0.126 | Cell adhesion inhibitor | 0.126 0.061 CID_154699676 | CID_154699676 | |
| 0.016 | 0.699 | 0.149 | Insulin secretagoues | 0.149 0.076 CID_154699676 | CID_154699676 | |
| 0.003 | 0.751 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.017 CID_154699714 | CID_154699714 | |
| 0.004 | 0.756 | 0.258 | Selectin antagonist | 0.064 0.047 CID_154699714 0.258 0.008 CID_154699676 | CID_154699676 | |
| 0.007 | 0.782 | 0.308 | Anticoagulant | 0.308 0.027 CID_154699714 0.119 0.114 CID_154699676 | CID_154699714 | |
| 0.009 | 0.785 | 0.083 | ATPase (Vacuolar H+) inhibitor | 0.083 0.071 CID_154699676 | CID_154699676 | |
| 0.007 | 0.786 | 0.247 | Free radical scavenger | 0.247 0.07 CID_154699676 | CID_154699676 | |
| 0.006 | 0.818 | 0.294 | Antioxidant | 0.294 0.064 CID_154699676 | CID_154699676 | |
| 0.006 | 0.833 | 0.07 | Protein 50S ribosomal subunit inhibitor | 0.07 0.024 CID_154699676 | CID_154699676 | |
| 0.008 | 0.847 | 0.047 | Glucose-6-phosphate translocase inhibitor | 0.047 0.044 CID_154699676 | CID_154699676 | |
| 0.007 | 0.857 | 0.193 | Nitric oxide antagonist | 0.193 0.07 CID_154699676 | CID_154699676 | |
| 0.002 | 0.863 | 0.255 | Cholecystokinin A agonist | 0.255 0.002 CID_154699714 | CID_154699714 | |
| 0.008 | 0.886 | 0.426 | Angiogenesis stimulant | 0.213 0.088 CID_154699714 0.426 0.018 CID_154699676 | CID_154699676 | |
| 0.002 | 0.885 | 0.32 | Cholecystokinin agonist | 0.32 0.003 CID_154699714 | CID_154699714 | |
| 0.012 | 0.937 | 0.259 | Hepatoprotectant | 0.259 0.041 CID_154699676 | CID_154699676 | |
| 0.006 | 0.936 | 0.249 | Apoptosis agonist | 0.249 0.216 CID_154699676 | CID_154699676 | |
| 0.005 | 0.939 | 0.499 | Cholecystokinin B agonist | 0.499 0.002 CID_154699714 | CID_154699714 | |
| 0.006 | 0.948 | 0.334 | Hypoglycemic | 0.334 0.042 CID_154699676 | CID_154699676 | |
| 0.005 | 0.953 | 0.367 | Antiinflammatory | 0.367 0.161 CID_154699676 | CID_154699676 | |
| 0.005 | 0.971 | 0.233 | Immunosuppressant | 0.233 0.163 CID_154699676 | CID_154699676 | |
| 0.005 | 0.982 | 0.193 | Apoptosis antagonist | 0.193 0.188 CID_154699676 | CID_154699676 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |